Literature DB >> 16239592

Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.

Florian Blaschke1, Yasunori Takata, Evren Caglayan, Ronald E Law, Willa A Hsueh.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. The 3 PPAR isotypes, PPAR-alpha, PPAR-gamma, and PPAR-delta, play a key role in the regulation of lipid and glucose metabolism. Obesity and the interrelated disorders of the metabolic syndrome have become a major worldwide health problem. In this review, we summarize the critical role of PPARs in regulating inflammation, lipoprotein metabolism, and glucose homeostasis and their potential implications for the treatment of obesity, diabetes, and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239592     DOI: 10.1161/01.ATV.0000191663.12164.77

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

Review 1.  The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.

Authors:  P C Manoria; H K Chopra; S K Parashar; A L Dutta; Brian Pinto; Ajit Mullasari; Samir Prajapati
Journal:  Indian Heart J       Date:  2013-11-25

2.  Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent.

Authors:  Bin Bao; Ananda S Prasad; Frances W J Beck; James T Fitzgerald; Diane Snell; Ginny W Bao; Tapinder Singh; Lavoisier J Cardozo
Journal:  Am J Clin Nutr       Date:  2010-04-28       Impact factor: 7.045

Review 3.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

Review 4.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

5.  Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.

Authors:  Vanessa F Merino; Mihail Todiras; Marcelo A Mori; Vicência M T Sales; Raphael G Fonseca; Vera Saul; Katja Tenner; Michael Bader; João B Pesquero
Journal:  J Mol Med (Berl)       Date:  2009-07-18       Impact factor: 4.599

Review 6.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

7.  Pharmacophore modeling and parallel screening for PPAR ligands.

Authors:  Patrick Markt; Daniela Schuster; Johannes Kirchmair; Christian Laggner; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

8.  Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study.

Authors:  Hsin-Chieh Yeh; Bruce B Duncan; Maria Inês Schmidt; Nae-Yuh Wang; Frederick L Brancati
Journal:  Ann Intern Med       Date:  2010-01-05       Impact factor: 25.391

Review 9.  Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.

Authors:  Sonia Villapol
Journal:  Cell Mol Neurobiol       Date:  2017-10-03       Impact factor: 5.046

10.  Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?

Authors:  Ahmad Aljada; Kshitij Ashwin Shah; Shaker A Mousa
Journal:  PPAR Res       Date:  2009-08-19       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.